Enzaline™

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).

ENZALINE is indicated for:, the treatment of patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with biochemical recurrence at high-risk for metastasis (high-risk BCR)., the treatment of patients with metastatic hormone-sensitive prostate cancer., the treatment of patients with non-metastatic castration-resistant prostate cancer (see PROSPER, section 5.1 - PHARMACODYNAMIC PROPERTIES - Clinical trials)., the treatment of patients with metastatic castration resistant prostate cancer following failure of androgen deprivation therapy in whom chemotherapy is not yet indicated., the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.

Source: ARTG

• Shelf lifetime is 24 Months
• Store below 30 degrees Celsius

Source: ARTG

Non-composite pack

This medicine contains one component only.

Component

• Capsule, soft
• Oral
• Clear liquid filled in opaque, peach coloured, oblong shape, soft gelatin capsules imprinted with C730

Source: ARTG

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.?What is the medicines and poisons schedule?

All medicines and poisons in Australia are categorised by how they are made available to the public. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. This system is called ‘scheduling’. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page.

• 112 soft capsules

Source: ARTG

This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.

Source: PBS

For the active ingredient: Enzalutamide

This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy. Do not stop taking this medicine abruptly without medical advice, as this may cause harm to you or your baby.

Source: AHT

If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).

You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)

Source: ARTG

Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).